GPR15 in colon cancer development and anti-tumor immune responses.

Saved in:
Bibliographic Details
Title: GPR15 in colon cancer development and anti-tumor immune responses.
Authors: Namkoong H; Division of Gastroenterology and Hepatology, Department of Medicine, School of Medicine, Stanford University, Stanford, CA, United States., Lee B; Division of Gastroenterology and Hepatology, Department of Medicine, School of Medicine, Stanford University, Stanford, CA, United States.; Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA, United States., Swaminathan G; Division of Gastroenterology and Hepatology, Department of Medicine, School of Medicine, Stanford University, Stanford, CA, United States., Koh SJ; Department of Internal Medicine, Liver Research Institute and Seoul National University College of Medicine, Seoul, Republic of Korea., Rogalla S; Division of Gastroenterology and Hepatology, Department of Medicine, School of Medicine, Stanford University, Stanford, CA, United States., Paraskevopoulou MD; GI Drug Discovery, Takeda Pharmaceuticals, Lexington, MA, United States., Tang J; Global Computation Biology, Takeda Pharmaceuticals, San Diego, CA, United States., Mikhail D; Division of Gastroenterology and Hepatology, Department of Medicine, School of Medicine, Stanford University, Stanford, CA, United States., Becker LS; Division of Gastroenterology and Hepatology, Department of Medicine, School of Medicine, Stanford University, Stanford, CA, United States., Habtezion A; Division of Gastroenterology and Hepatology, Department of Medicine, School of Medicine, Stanford University, Stanford, CA, United States.; Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Stanford, CA, United States.
Source: Frontiers in oncology [Front Oncol] 2023 Nov 24; Vol. 13, pp. 1254307. Date of Electronic Publication: 2023 Nov 24 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2234-943X
DOI:10.3389/fonc.2023.1254307